ID PA217_AUSSU Reviewed; 152 AA. AC Q9PUG7; DT 01-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 25-NOV-2008, entry version 45. DE RecName: Full=Phospholipase A2 isozyme S17-58; DE EC=3.1.1.4; DE AltName: Full=Phosphatidylcholine 2-acylhydrolase; DE AltName: Full=ASPLA17; DE Flags: Precursor; OS Austrelaps superbus (Australian copperhead). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Scleroglossa; Serpentes; Colubroidea; OC Elapidae; Acanthophiinae; Austrelaps. OX NCBI_TaxID=29156; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RX MEDLINE=20166950; PubMed=10700385; DOI=10.1006/abbi.1999.1672; RA Singh S.B., Armugam A., Kini R.M., Jeyaseelan K.; RT "Phospholipase A(2) with platelet aggregation inhibitor activity from RT Austrelaps superbus venom: protein purification and cDNA cloning."; RL Arch. Biochem. Biophys. 375:289-303(2000). CC -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2- CC acyl groups in 3-sn-phosphoglycerides. Inhibits collagen-induced CC platelet aggregation (By similarity). CC -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1- CC acylglycerophosphocholine + a carboxylate. CC -!- COFACTOR: Calcium (Probable). CC -!- SUBCELLULAR LOCATION: Secreted (By similarity). CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF184143; AAD56410.1; -; mRNA. DR HSSP; P00593; 4BP2. DR HOVERGEN; Q9PUG7; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro. DR GO; GO:0016042; P:lipid catabolic process; IEA:InterPro. DR GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW. DR GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro. DR InterPro; IPR016090; Phospholipase_A2. DR InterPro; IPR013090; Phospholipase_A2_AS. DR InterPro; IPR001211; Phospholipase_A2_euk. DR Gene3D; G3DSA:1.20.90.10; Phospholipase_A2; 1. DR PANTHER; PTHR11716; Phospholipase_A2; 1. DR Pfam; PF00068; Phospholip_A2_1; 1. DR PRINTS; PR00389; PHPHLIPASEA2. DR ProDom; PD000303; PhospholipaseA2; 1. DR SMART; SM00085; PA2c; 1. DR PROSITE; PS00119; PA2_ASP; 1. DR PROSITE; PS00118; PA2_HIS; 1. PE 2: Evidence at transcript level; KW Calcium; Hydrolase; Lipid degradation; Metal-binding; Secreted; KW Signal; Toxin. FT SIGNAL 1 19 Potential. FT PROPEP 20 27 Potential. FT /FTId=PRO_0000022817. FT CHAIN 28 152 Phospholipase A2 isozyme S17-58. FT /FTId=PRO_0000022818. FT ACT_SITE 75 75 By similarity. FT ACT_SITE 126 126 By similarity. FT METAL 55 55 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 57 57 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 59 59 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 76 76 Calcium (By similarity). FT DISULFID 38 104 By similarity. FT DISULFID 54 151 By similarity. FT DISULFID 56 72 By similarity. FT DISULFID 71 132 By similarity. FT DISULFID 78 125 By similarity. FT DISULFID 88 118 By similarity. FT DISULFID 111 123 By similarity. SQ SEQUENCE 152 AA; 16641 MW; 0F2BD5BDDCF04FCB CRC64; MYPAHLLVLL AVCVSLLGAS NIPLPSLDFE QFGKMIQCTI PCEESCLAYM DYGCYCGPGG SGTPSDELDR CCQTHDNCYA EAGKLPACKA MLSEPYNDTY SYSCIERQLT CNDDNDECKA FICNCDRAAV ICFSGAPYND SNYDIGTIEH CK //